Search results for "Liver function tests"

showing 9 items of 79 documents

Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome.

2004

Background & Aims: The HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome is a life-threatening complication during pregnancy. The associated liver disease may be severe, and maternal hepatic complications may progress to the point that transplantation becomes necessary. CD95 (APO-1, Fas)-mediated apoptosis of liver cells is one of the major pathogenic mechanisms during liver disease. The interaction of CD95 with its ligand, CD95L(FasL), induces apoptosis and thus the source of the death-inducing ligand is critical for understanding the pathomechanism of liver damage involving the CD95-system. Methods: Sera from HELLP patients were analyzed and used in cell culture experiment…

medicine.medical_specialtyHELLP SyndromeFas Ligand ProteinHELLP syndromePlacentaApoptosisBiologyHepatic ComplicationFas ligandAcute fatty liver of pregnancyLiver diseaseJurkat CellsMicePregnancyInternal medicinemedicineAnimalsHumansCells CulturedTransaminasesMembrane GlycoproteinsHepatologymedicine.diagnostic_testLiver cellGastroenterologymedicine.diseaseHemolysisMolecular WeightEndocrinologyLiverCancer researchHepatocytesFemaleLiver function testsGastroenterology
researchProduct

Barbiturate jaundice

1969

Summary A case of barbital-induced jaundice is described. The patient, a 31-year-old woman, developed generalized skin eruption, mucosal lesions, and fever 2 hr after the ingestion of 2 tablets of a barbital-containing drug (Veramon). She then developed a deep cholestatic jaundice which lasted more than 7 months. During the remission of jaundice, a rechallenge with phenobarbital caused a recurrence of fever and skin eruption, with exacerbation of jaundice.

medicine.medical_specialtyHepatologybiologyExacerbationmedicine.diagnostic_testbusiness.industrymedicine.drug_classGastroenterologyJaundiceBarbitalGastroenterologyAlanine transaminaseBarbiturateAnesthesiaInternal medicinebiology.proteinMedicineIngestionPhenobarbitalmedicine.symptombusinessLiver function testsmedicine.drugGastroenterology
researchProduct

Predictors of mortality and early detection strategies for hepatopulmonary syndrome in liver transplant patients☆

2016

Introduction: Hepatopulmonary syndrome (HPS) is a serious, progressive disease. Its pathophysiology resides in a hypoxic intrapulmonary shunt and severe clinical deterioration. Liver transplantation (LT) is the only effective treatment in appropriately selected patients. Objective: To acknowledge the importance of early diagnosis of HPS. Patients and methods: Observational, descriptive, retrospective trial including 8 patients with HPS that received LT between April 2006 and August 2014. The clinical data prior to transplantation and follow-up after the procedure were reviewed. A multivariate analysis (stepwise forward logistic regression analysis) was used to identify the variable that cou…

medicine.medical_specialtyHepatopulmonary syndromemedicine.medical_treatment030230 surgeryLiver transplantationCritical Care and Intensive Care MedicineGastroenterologyHypoxemiaAnestesiaBile canaliculus03 medical and health sciencesLiver disease0302 clinical medicineSíndrome hepatopulmonarInternal medicinemedicineHepatic insufficiencyAnesthesiaMortalityHepatopulmonary syndromeSurvival rateTransplante de hígadoHepatitisLiver transplantationmedicine.diagnostic_testbusiness.industryInsuficiencia hepáticaPolycystic liver diseasemedicine.diseaseSurgeryTransplantationmedicine.anatomical_structureAnesthesiology and Pain MedicineHepatocyteMortalidadPortal hypertension030211 gastroenterology & hepatologyTransplant patientmedicine.symptomLiver function testsbusinessProgressive diseaseColombian Journal of Anesthesiology
researchProduct

Evidence-based medicine and the problem of healthy volunteers

2017

Abstract Healthy controls are subjects without the disease being studied but may have other conditions indirectly affecting outcome. In the present epidemics of obesity a few subjects with undiagnosed nonalcoholic fatty liver disease enter clinical studies as controls, producing biased results. Stricter selection criteria should be considered to prevent this risk.

medicine.medical_specialtyLiver EnzymesSpecialties of internal medicinePredictive Value of TestDiseaseGastroenterology03 medical and health sciences0302 clinical medicineClinical trialsLiver Function TestsPredictive Value of TestsReference ValuesNon-alcoholic Fatty Liver DiseaseLiver enzymeInternal medicineNAFLDHealthy volunteersNonalcoholic fatty liver diseasemedicineHumansReference ValueObesitySelection (genetic algorithm)Evidence-Based MedicineHepatologybusiness.industryLiver Function TestPatient SelectionLiver enzymeControl groupGeneral MedicineEvidence-based medicineClinical trials. Control group. Liver Enzymes. NAFLD. Obesitymedicine.diseaseObesityHealthy VolunteerHealthy VolunteersClinical trialClinical trialRC581-951030211 gastroenterology & hepatologybusiness030217 neurology & neurosurgeryHuman
researchProduct

Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey

2014

Background and Aims Inflammatory bowel diseases (IBD) are frequently associated with altered liver function tests (LFTs). The causal relationship between abnormal LFTs and IBD is unclear. The aim of our study was to evaluate the prevalence and etiology of LFTs abnormalities and their association with clinical variables in a cohort of IBD patients followed up in a single center. Materials and Methods A retrospective review was undertaken of all consecutive IBD in- and outpatients routinely followed up at a single referral center. Clinical and demographic parameters were recorded. Subjects were excluded if they had a previous diagnosis of chronic liver disease. LFT abnormality was defined as …

medicine.medical_specialtyPathologySettore MED/09 - Medicina Internadrug-induced hepatotoxicityChronic liver diseaseInflammatory bowel diseaseGastroenterologyCholestasisinflammatory bowel diseaseInternal medicinemedicinelcsh:RC799-869Original Researchfatty liverLiver injurymedicine.diagnostic_testbusiness.industryFatty liverGastroenterologymedicine.diseaseCohortEtiologylcsh:Diseases of the digestive system. Gastroenterologyliver function testsbusinessLiver function testsClinical Medicine Insights: Gastroenterology
researchProduct

Implication of Normal Liver Enzymes in Liver Disease

2009

Summary.  Chronic liver disease is usually asymptomatic until its late stages and also significant hepatic necroinflammation and fibrosis may be present in persistently normal ALT levels HBV, HCV carriers or similarly, in patients with nonalcoholic fatty liver disease. Given the large number of persons in the general population which may harbor a clinically significant liver disease behind the screen of normal alanine aminotransferase, more attention should be devoted to future research for alternative noninvasive markers of liver damage.

medicine.medical_specialtyPopulationChronic liver diseaseaminotransferases chronic hepatitis liver fibrosisGastroenterologySensitivity and SpecificityLiver diseaseVirologyInternal medicineNonalcoholic fatty liver diseasemedicineHumanseducationeducation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryLiver DiseasesFatty liverAlanine TransaminaseHepatitis Cmedicine.diseaseInfectious DiseasesLiverHepatic fibrosisLiver function testsbusiness
researchProduct

Optimizing diagnostic approach to drug-induced liver injury

2018

Drug-induced liver injury (DILI) is often a trial even to expert clinicians, because sometimes diagnosis is not easy to be made. Guidelines of the American College of Gastroenterology (ACG) yielded in 2014, help to better understand the problem. The diagnosis of DILI is made through a detailed evaluation of clinical, serological, radiological and histological aspects. Biochemical data include liver function tests that allow to assess the pattern of damage, such as hepatocellular, cholestatic and mixed liver injury; serological data include testing for major and possibly minor hepatotropic viruses, non-organ specific autoantibodies. Clinical scenario might include jaundice, nausea, vomiting …

medicine.medical_specialtySettore MED/09 - Medicina InternaDrug-induced liver injurydiagnosisclinical approach.lcsh:MedicineClinical approach03 medical and health sciencesDrug withdrawalLiver disease0302 clinical medicinemedicineEosinophiliaLiver injurymedicine.diagnostic_testbusiness.industryMedicine (all)lcsh:RGeneral MedicineJaundicemedicine.disease030220 oncology & carcinogenesisLiver biopsy030211 gastroenterology & hepatologyRadiologymedicine.symptomTransient elastographybusinessLiver function testsDiagnosiItalian Journal of Medicine
researchProduct

Randomized clinical trial comparing liver resection with and without perioperative assessment of liver function

2018

Background Liver function tests may help to predict outcomes after liver surgery. The aim of this study was to evaluate the clinical impact on postoperative outcome and patient management of perioperative liver function testing using the LiMAx® test. Methods A multicentre RCT was conducted in six academic liver centres. Patients with intrahepatic tumours scheduled for open liver resection of at least one segment were eligible. Patients were randomized to undergo additional perioperative liver function tests (LiMAx® group) or standard care (control group). Patients in the intervention arm received two perioperative LiMAx® tests, one before the operation for surgical planning and another afte…

medicine.medical_specialtymedicine.diagnostic_testSurrogate endpointbusiness.industryIncidence (epidemiology)General MedicinePerioperative030230 surgeryIntensive care unitlaw.inventionSurgery03 medical and health sciences0302 clinical medicineRandomized controlled triallaw030220 oncology & carcinogenesisClinical endpointmedicineLiver functionLiver function testsbusinessBJS Open
researchProduct

A single transient episode of hyperammonemia induces long-lasting alterations in protein kinase A.

2007

A single transient episode of hyperammonemia induces long-lasting alterations in protein kinase A. Am J Physiol Gastrointest Liver Physiol 292: G305-G314,2007; doi:10.1152/ajpgi.00100.2006.-Hepatic encephalopathy in patients with liver disease is associated with poor prognosis. This could be due to the induction by the transient episode of hepatic encephalopathy of long-lasting alterations making patients more susceptible. We show that a single transient episode of hyperammonemia induces long-lasting alterations in signal transduction. The content of the regulatory subunit of the protein kinase dependent on cAMP (PKA-RI) is increased in erythrocytes from cirrhotic patients. This increase is…

soluble guanylate cyclaseAdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisErythrocytesPhysiologyliver cirrhosisEncephalopathyhepatic encephalopathyBiologyHepatitisLiver diseaseLiver Function TestsReference ValuesPhysiology (medical)Internal medicinemedicineAnimalsHumansHyperammonemiaRats WistarProtein kinase AHepatic encephalopathyAgedHepatologyPortacaval anastomosisMetabolic disorderErythrocyte MembraneGastroenterologyAscitesHyperammonemiaMiddle Agedmedicine.diseaseCyclic AMP-Dependent Protein KinasesRatsDisease Models AnimalEndocrinologyChronic Diseaserat modelsFemaleLiver FailureAmerican journal of physiology. Gastrointestinal and liver physiology
researchProduct